文献速递生殖医学产科

多囊卵巢综合征母亲所生儿童的肛门生殖器距离:欧登塞儿童队列研究

Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort.
PubMed 文献 · Hum Reprod · 2019-01-01

该研究基于欧登塞儿童队列,纳入多囊卵巢综合征(PCOS)母亲139例与对照1422例,于妊娠第28周用质谱法测母体睾酮,并在子代3月龄时测肛门生殖器距离(AGD)。结果发现PCOS母亲子代AGD与对照相似(均P>0.2),尽管PCOS组总睾酮与游离睾酮显著更高。

要点

  • PCOS母亲子代3月龄时AGD与对照相比无显著差异(均P>0.2)。
  • PCOS组母体总睾酮均值2.4 vs 对照2.0 nmol/l,游离睾酮均值0.005 vs 0.004 nmol/l(均P<0.001)。
  • 在PCOS母亲中,母体睾酮是男婴AGDas与AGDap的独立正向预测因子。

核心结论

  • PCOS母亲所生3月龄儿童的AGD与对照组相似。
  • 作者认为成年PCOS女性较长的AGD可能是青春期睾酮升高并可能伴随体重增加的结果。

研究设计与样本

  • 研究为前瞻性欧登塞儿童队列(OCC)的一部分,纳入PCOS母亲139例与对照1422例。
  • 于妊娠第28周用质谱法测定1127名女性的母体睾酮水平。
  • PCOS诊断依据鹿特丹标准,于孕前作出。
  • 子代于3月龄时测量AGD(女婴肛门至后阴唇系带AGDaf及至阴蒂AGDac;男婴至阴囊AGDas及至阴茎AGDap)及阴茎宽度和体成分(体重与BMI标准差评分)。
  • 对照人群为受孕前月经周期规律(<35天)且无雄激素过多体征(多毛和/或痤疮)的女性。

主要发现

  • PCOS母亲子代与对照子代的AGD测量值相当(所有P>0.2)。
  • PCOS组母体总睾酮均值2.4 vs 对照2.0 nmol/l,游离睾酮均值0.005 vs 0.004 nmol/l(均P<0.001)。
  • 在PCOS女性中,母体睾酮是男婴AGDas和AGDap的独立正向预测因子。
  • 母体睾酮未预测PCOS母亲所生女婴的AGD,也未预测对照组所生男婴或女婴的AGD。

局限性

  • PCOS诊断基于回顾性信息和孕期问卷。
  • 参与OCC的女性相比背景人群种族更同质、更瘦、受教育程度更高且更少吸烟。
  • 研究结果需在PCOS前瞻性队列、更肥胖人群及其他种族女性中重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are higher testosterone levels during pregnancy in women with polycystic ovary syndrome (PCOS) associated with longer offspring anogenital distance (AGD)? SUMMARY ANSWER: AGD was similar in 3-month-old children born of mothers with PCOS compared to controls. WHAT IS KNOWN ALREADY: AGD is considered a marker of prenatal androgenization. STUDY DESIGN, SIZE, DURATION: Maternal testosterone levels were measured by mass spectrometry at Gestational Week 28 in 1127 women. Maternal diagnosis of PCOS before pregnancy was defined according to Rotterdam criteria. Offspring measures included AGD from anus to posterior fourchette (AGDaf) and clitoris (AGDac) in girls and to scrotum (AGDas) and penis (AGDap) and penile width in boys and body composition (weight and BMI SD scores) at age 3 months. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was part of the prospective study, Odense Child Cohort (OCC), and included mothers with PCOS (n = 139) and controls (n = 1422). The control population included women with regular menstrual cycles (<35 days) before conception and no signs of androgen excess (hirsutism and/or acne). MAIN RESULTS AND THE ROLE OF CHANCE: AGD measures were comparable in offspring of women with PCOS compared to controls (all P > 0.2) despite significantly higher maternal levels of total testosterone (mean: 2.4 versus 2.0 nmol/l) and free testosterone (mean: 0.005 versus 0.004 nmol/l) in women with PCOS versus controls (both P < 0.001). In women with PCOS, maternal testosterone was an independent positive predictor of offspring AGDas and AGDap in boys. Maternal testosterone levels did not predict AGD in girls born of mothers with PCOS or in boys or girls born of women in the control group. LIMITATIONS, REASONS FOR CAUTION: The diagnosis of PCOS was based on retrospective information and questionnaires during pregnancy. Women participating in OCC were more ethnically homogenous, leaner, more educated and less likely to smoke compared to the background population. Our study findings, therefore, need to be reproduced in prospective study cohorts with PCOS, in more obese study populations and in women of other ethnicities. WIDER IMPLICATIONS OF THE FINDINGS: Our finding of the same AGD in girls born of mothers with PCOS compared to controls expands previous results of studies reporting longer AGD in adult women with PCOS. Our results suggest that longer AGD in adult women with PCOS could be the result of increased testosterone levels in puberty, perhaps in combination with weight gain. STUDY FUNDING/COMPETING INTEREST(S): Financial grants for the study were provided by the Danish Foundation for Scientific Innovation and Technology (09-067180), Ronald McDonald Children Foundation, Odense University Hospital, the Region of Southern Denmark, the Municipality of Odense, the Mental Health Service of the Region of Southern Denmark, The Danish Council for Strategic Research, Program Commission on Health, Food and Welfare (2101-08-0058), Odense Patient data Explorative Network, Novo Nordisk Foundation (grant no. NNF15OC00017734), the Danish Council for Independent Research and the Foundation for research collaboration between Rigshospitalet and Odense University Hospital and the Health Foundation (Helsefonden). There is no conflict of interest of any author that could be perceived as prejudicing the impartiality of the research reported.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Glintborg D, Jensen RC, Schmedes AV, et al. Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort. Hum Reprod. 2019. PMID: 31560039. doi:10.1093/humrep/dez122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。